Use of viral promoters in mammalian cell-based bioassays: How reliable?

被引:2
|
作者
Betrabet S.S. [1 ]
Choudhuri J. [1 ]
Gill-Sharma M. [1 ]
机构
[1] Natl. Inst. for Res. in Repro. Hlth., ICMR, Parel, Mumbai 400 012, Jahangir Merwanji Street
关键词
Reporter Vector; Viral Promoter; Chloramphenicol Acetyl Transferase; Reporter Gene Construct; Human Therapy;
D O I
10.1186/1479-5876-2-1
中图分类号
学科分类号
摘要
Cell-based bioassays have been suggested for screening of hormones and drug bioactivities. They are a plausible alternative to animal based methods. The technique used is called receptor/reporter system. Receptor/reporter system was initially developed as a research technique to understand gene function. Often reporter constructs containing viral promoters were used because they could be expressed with very 'high' magnitude in a variety of cell types in the laboratory. On the other hand mammalian genes are expressed in a cell/tissue specific manner, which makes them (i.e. cells/tissues) specialized for specific function in vivo. Therefore, if the receptor/reporter system is to be used as a cell-based screen for testing of hormones and drugs for human therapy then the choice of cell line as well as the promoter in the reporter module is of prime importance so as to get a realistic measure of the bioactivities of 'test' compounds. We evaluated two conventionally used viral promoters and a natural mammalian promoter, regulated by steroid hormone progesterone, in a cell- based receptor/reporter system. The promoters were spliced into vectors expressing enzyme CAT (chloramphenicol acetyl transferase), which served as a reporter of their magnitudes and consistencies in controlling gene expressions. They were introduced into breast cell lines T47D and MCF-7, which served as a cell-based source of progesterone receptors. The yardstick of their reliability was highest magnitude as well as consistency in CAT expression on induction by sequential doses of progesterone. All the promoters responded to induction by progesterone doses ranging from 10-12 to 10-6 molar by expressing CAT enzyme, albeit with varying magnitudes and consistencies. The natural mammalian promoter showed the most coherence in magnitude as well as dose dependent expression profile in both the cell lines. Our study casts doubts on use of viral promoters in a cell-based bioassay for measuring bioactivities of drugs and hormones for human therapy and suggests caution regardingtranslation in toto, of a research technique as a cell-based bioassay for drug screening. © 2004 Betrabet et al; licensee BioMed Central Ltd.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Quantitative cell-based bioassays to advance immunotherapy programs targeting immune checkpoint receptors
    Ott, Vanessa
    Grailer, Jamison
    Wang, Jun
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Beck, Michael
    Hartnett, Jim
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-jie Jey
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [42] In Vitro Cell-Based Bioassays for Screening and Comparison of the TNFα and IL-17A Inhibitors
    Ossina, N. K.
    Pugachev, E. I.
    Orlov, E. V.
    Volova, L. T.
    APPLIED BIOCHEMISTRY AND MICROBIOLOGY, 2023, 59 (08) : 1118 - 1123
  • [43] In Vitro Cell-Based Bioassays for Screening and Comparison of the TNFα and IL-17A Inhibitors
    N. K. Ossina
    E. I. Pugachev
    E. V. Orlov
    L. T. Volova
    Applied Biochemistry and Microbiology, 2023, 59 : 1118 - 1123
  • [44] Application of cell-based bioassays to evaluate treatment efficacy of conventional and intensified treatment wetlands
    Nivala, Jaime
    Neale, Peta A.
    Haasis, Tobias
    Kahl, Stefanie
    Koenig, Maria
    Mueller, Roland A.
    Reemtsma, Thorsten
    Schlichtinge, Rita
    Escher, Beate I.
    ENVIRONMENTAL SCIENCE-WATER RESEARCH & TECHNOLOGY, 2018, 4 (02) : 206 - 217
  • [45] Quantitative cell-based bioassays to advance immunotherapy programs targeting immune checkpoint receptors
    Grailer, Jamison
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Wang, Jun
    Beck, Michael
    Hartnett, Jim
    Krishnan, Gopal
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-jie Jey
    CANCER RESEARCH, 2019, 79 (13)
  • [46] A High Throughput Cell-based System for Screening Synthetic Promoters in Crop Plants
    Waibel, T.
    Brzezek, K.
    Critchley, J. H.
    Roberts, M. L.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2015, 51 : S18 - S18
  • [47] Surface Engineering for Cell-Based Therapies: Techniques for Manipulating Mammalian Cell Surfaces
    Abbina, Srinivas
    Siren, Erika M. J.
    Moon, Haisle
    Kizhakkedathu, Jayachandran N.
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2018, 4 (11): : 3658 - 3677
  • [48] Novel cell-based bioassays enable preclinical animal studies during immunooncology drug development
    Wang, Jun
    Garvin, Denise
    Perrin, Elizabeth
    Hartnett, Jim
    Cong, Mei
    Grailer, Jamison
    CANCER RESEARCH, 2024, 84 (06)
  • [49] Cell-Based Therapy for RDEB: How Does It Work?
    Uitto, Jouni
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (08) : 1597 - 1599
  • [50] Integration of Biofuel Cell-Based Self-Powered Biosensing and Homogeneous Electrochemical Strategy for Ultrasensitive and Easy-To-Use Bioassays of MicroRNA
    Gai, Panpan
    Gu, Chengcheng
    Hou, Ting
    Li, Feng
    ACS APPLIED MATERIALS & INTERFACES, 2018, 10 (11) : 9325 - 9331